K-ras Mutations and Prognosis in Large-Bowel Carcinomas

References

• Dukes C E, Bussey H J R. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12: 309–20
   PubMed Web of Science ®Google Scholar
• Turnbull R B, Kyle K, Watson F R, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967; 166: 420–7
   PubMed Web of Science ®Google Scholar
• Remmele W, Heine M. Pathologisch-analomische Begulachtung Kolorektaler Karzinome unter proenostischen Gesiehtspunkten. Med Welt 1981; 32: 771–7
   PubMedGoogle Scholar
• Wanebo H J, Rao B, Pinsky C M, Hoffmann R G, Stearns M, Schwartz M K, et al. Preoperative carcinoembryonie antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299: 448–51
   PubMed Web of Science ®Google Scholar
• Rognum T O. A new approach in carcinoembryonic antigenguided follow-up of large-bowel carcinoma patients. Scand J Gastroenterol 1986; 21: 641–9
   PubMed Web of Science ®Google Scholar
• Meling G I, Rognum T O, Clausen O P F, Børmer O, Lunde O C, Schlichting E, et al. Serum carcinoembryonic antigen in relation to survival, DNA ploidy pattern, and recurrent disease in 406 colorectal carcinoma patients. Scand J Gastroenterol 1992; 27: 1061–8
   PubMed Web of Science ®Google Scholar
• Wolley R C, Schreiber K, Koss L G, Karas M, Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J Natl Cancer Inst 1982; 69: 15–22
   PubMedGoogle Scholar
• Rognum T O, Thorud E, Lund E. Survival of large bowel carcinoma patients with different DNA ploidv. Br J Cancer 1987; 56: 633–6
   PubMed Web of Science ®Google Scholar
• Rognum T O, Lund E, Meling G I, Langmark F. Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 1991; 68: 1077–81
   PubMed Web of Science ®Google Scholar
• Norheim Andersen S, Rognum T O, Lund E, Meling G I, Hauge S. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer 1993; 68: 80–5
   PubMed Web of Science ®Google Scholar
• Bos J L, Fearon E R, Hamilton S R, Verlaan-de Vries M, van Boom J H, van der Eb A J, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–7
   PubMed Web of Science ®Google Scholar
• Forrester K, Almoguera C, Han K, Grizzle W E, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298–303
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Fearon E R, Hamilton S R, Kern S E, Preisingcr A C, Leppert M, et al. Genetic alterations during colorectaltumor development. N Engl J Med 1988; 319: 525–32
   PubMed Web of Science ®Google Scholar
• Burmer G C, Loeb L A. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 1989; 86: 2403–7
   PubMed Web of Science ®Google Scholar
• McLellan E A, Owen R A, Stepniewska K A, Sheffield J P, Lemoine N R. High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 1993; 34: 392–6
   PubMed Web of Science ®Google Scholar
• Suchy B, Zietz C, Rabes H M. K-ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis. Int J Cancer 1992; 52: 30–3
   PubMed Web of Science ®Google Scholar
• Finkelstein S D, Sayegh R, Christensen S, Swalsky P A. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer 1993; 71: 3827–38
   PubMed Web of Science ®Google Scholar
• Finkelstein S D, Sayegh R, Bakker A, Swaksky P. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 1993; 128: 526–32
   PubMed Web of Science ®Google Scholar
• Benhattar J, Losi L, Chaubert P, Givel J-C, Costa J. Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 1993; 104: 1044–8
   PubMed Web of Science ®Google Scholar
• Moerkerk P, Arends J W, van Driel M, de Bruïne A, de Goeij A, ten Kate J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 1994; 54: 3376–8
   PubMed Web of Science ®Google Scholar
• Breivik J, Meling G I, Spurkland A, Rognum T O, Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer 1994; 69: 367–71
   PubMed Web of Science ®Google Scholar
• Ashley D J B. Evans' histological appearance of tumours3rd ed. Livingstone, Edinburgh 1978; 582–7
   Google Scholar
• Rognum T O, Heier H E, Ørjasaeter H, Thorud E, Brandtzaeg P. Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different DNA ploidy pattern. Eur J Clin Oncol 1986; 22: 1165–9
   PubMedGoogle Scholar
• Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology 1974; 26: 1101–14
   PubMed Web of Science ®Google Scholar
• Kahn S M, Jiang W, Culbertson T A, Weinstein B, Williams G M, Tomita N, et al. Rapid and sensitive nonradioactive detection of mutant K-ras genes via ‘enriched’ PCR amplification. Oncogene 1991; 6: 1079–83
   PubMed Web of Science ®Google Scholar
• Norheim Andersen S, Breivik J, Løvig T, Meling G I, Gaudernack G, Clausen O P F, et al. K-ras mutations and HLA-DR expression in large bowel adenomas. Br J Cancer 1996; 74: 99–108
   PubMed Web of Science ®Google Scholar
• Sanger F, Niclen S, Coulsen A R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–7
   PubMed Web of Science ®Google Scholar
• Cox D. Regression models and life tables. J Royal Stat Soc (B) 1972; 34: 187–200
   Google Scholar
• Shibata D, Schaeffer J, Li Z-H, Capella G, Perucho M. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 1993; 85: 1058–63
   PubMed Web of Science ®Google Scholar
• Soh K, Yanagisawa A, Hiratsuka H, Sugano H, Kato Y. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res 1993; 84: 388–93
   PubMedGoogle Scholar
• Losi L, Benhattar J, Costa J. Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 1992; 28A: 1115–20
   PubMed Web of Science ®Google Scholar
• Kastrinakis W V, Ramchurren N, Maggard M, Steele G, Jr, Summerhayes I C. K-ras status does not predict successful hepatic resection of colorectal cancer metastasis. Arch Surg 1995; 130: 9–14
   PubMedGoogle Scholar
• Pricolo V E, Finkelstein S D, Wu T-T, Keller G, Bakker A, Swalsky P A, et al. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 1996; 171: 41–6
   PubMed Web of Science ®Google Scholar
• Laurent-Puig P, Olschwang S, Delattre O, Remvikos Y, Asselain B, Melot T, et al. Survival and aquired genetic alterations in colorectal cancer. Gastroenterology 1992; 102: 1136–41
   PubMed Web of Science ®Google Scholar
• Tanaka M, Omura K, Watanabe Y, Oda Y, Nakanishi I. Prognostic factors of colorectal cancer: K-ras mutation, over-expression of the p53 protein, and cell proliferative activity. J Surg Oncol 1994; 57: 57–64
   PubMed Web of Science ®Google Scholar
• Dix B R, Robbins P, Soong R, Jenner D, House A K, Iacopetta B J. The General Surgeons at Sir Charles Gairdner Hospital. The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 1994; 59: 747–51
   PubMed Web of Science ®Google Scholar
• Bell S M, Scott N, Cross D, Sagar P, Lewis F A, Blair G E, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993; 104: 57–64
   PubMed Web of Science ®Google Scholar